Literature DB >> 2938475

Ocular rosacea in blacks.

D J Browning, G Rosenwasser, M Lugo.   

Abstract

In three black men (57, 64, and 61 years old) with the ocular manifestations of rosacea, the diagnosis was not initially suspected because the pathognomonic skin changes of rosacea were obscured by the skin hyperpigmentation. Ocular involvement ranged from blepharitis and conjunctival hyperemia to sight-threatening problems such as corneal neovascularization, thinning, ulceration, and perforation. Treatment with oral tetracycline and topical corticosteroids appeared to be as effective in these patients as in previously described white patients.

Entities:  

Mesh:

Year:  1986        PMID: 2938475     DOI: 10.1016/0002-9394(86)90644-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Ocular acne rosacea in tertiary eye center in Saudi Arabia.

Authors:  Mohammad A Al-Amry; Huda A Al-Ghadeer
Journal:  Int Ophthalmol       Date:  2016-12-30       Impact factor: 2.031

2.  Use of Crossed Polarizers to Enhance Images of the Eyelids.

Authors:  Ryan OʼSullivan; Lisa M Tom; Vatinee Y Bunya; William C Nyberg; Mina Massaro-Giordano; Ebenezer Daniel; Eli Smith; David H Brainard; James Gee; Maureen G Maguire; Richard A Stone
Journal:  Cornea       Date:  2017-05       Impact factor: 2.651

3.  Spontaneous corneal perforation in ocular rosacea.

Authors:  Khalid Al Arfaj; Waseem Al Zamil
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

4.  Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea.

Authors:  D V Seal; P Wright; L Ficker; K Hagan; M Troski; P Menday
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

5.  Ocular Rosacea Causing Corneal Melt in an African American Patient and a Hispanic Patient.

Authors:  Joanna S Saade; Bachir Abiad; Jonathan Jan; Dana Saadeh; James P McCulley; Jeremy Bartley
Journal:  Case Rep Ophthalmol Med       Date:  2017-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.